Request Sample Inquiry
Fusion Biopsy Market

Fusion Biopsy Market

Fusion Biopsy Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

145

Base Year:

2022

Date

Sep - 2023

Format:

PDF XLS PPT

Report Code:

VMR-2280

Segments Covered
  • By Biopsy Route By Biopsy Route Transrectal, Transperineal
  • By End-Use By End-Use Hospitals, Diagnostic Centers, Ambulatory Care Centers
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 425.9 Million
Revenue 2030Revenue 2030: USD 929.8 Million
Revenue CAGRRevenue CAGR (2023 - 2030): 11.8%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): Asia Pacific
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Fusion Biopsy Market - Segment Analysis
    1. Overview
    2. Global Fusion Biopsy Market, 2016 - 2028 (USD Million)
    3. Global Fusion Biopsy Market - by Biopsy Route
      1. By Transrectal
      2. By Transperineal
    4. Global Fusion Biopsy Market - by End-Use
      1. By Hospitals
      2. By Diagnostic Centers
      3. By Ambulatory Care Centers
    5. Global Fusion Biopsy Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    6. Market comparative analysis
  4. North America Fusion Biopsy Market - Segment Analysis
    1. Overview
    2. North America Fusion Biopsy Market, 2016 - 2028 (USD Million)
    3. North America Fusion Biopsy Market, by Biopsy Route
      1. By Transrectal
      2. By Transperineal
    4. North America Fusion Biopsy Market, by End-Use
      1. By Hospitals
      2. By Diagnostic Centers
      3. By Ambulatory Care Centers
    5. North America Fusion Biopsy Market, by Country
      1. U.S.
        1. U.S. Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. U.S. Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
      2. Canada
        1. Canada Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. Canada Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
      3. Mexico
        1. Mexico Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. Mexico Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
  5. Europe Fusion Biopsy Market - Segment Analysis
    1. Overview
    2. Europe Fusion Biopsy Market, 2016 - 2028 (USD Million)
    3. Europe Fusion Biopsy Market, by Biopsy Route
      1. By Transrectal
      2. By Transperineal
    4. Europe Fusion Biopsy Market, by End-Use
      1. By Hospitals
      2. By Diagnostic Centers
      3. By Ambulatory Care Centers
    5. Europe Fusion Biopsy Market, by Country
      1. Germany
        1. Germany Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. Germany Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
      2. UK
        1. UK Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. UK Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
      3. France
        1. France Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. France Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
      4. Spain
        1. Spain Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. Spain Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
      5. Italy
        1. Italy Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. Italy Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
      6. BENELUX
        1. BENELUX Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. BENELUX Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
      7. Rest of Europe
        1. Rest Of Europe Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. Rest Of Europe Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
  6. Asia Pacific Fusion Biopsy Market - Segment Analysis
    1. Overview
    2. Asia Pacific Fusion Biopsy Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Fusion Biopsy Market, by Biopsy Route
      1. By Transrectal
      2. By Transperineal
    4. Asia Pacific Fusion Biopsy Market, by End-Use
      1. By Hospitals
      2. By Diagnostic Centers
      3. By Ambulatory Care Centers
    5. Asia Pacific Fusion Biopsy Market, by Country
      1. China
        1. China Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. China Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
      2. Japan
        1. Japan Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. Japan Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
      3. India
        1. India Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. India Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
      4. South Korea
        1. South Korea Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. South Korea Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
      5. South East Asia
        1. South East Asia Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. South East Asia Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. Rest of Asia Pacific Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
  7. Latin America Fusion Biopsy Market - Segment Analysis
    1. Overview
    2. Latin America Fusion Biopsy Market, 2016 - 2028 (USD Million)
    3. Latin America Fusion Biopsy Market, by Biopsy Route
      1. By Transrectal
      2. By Transperineal
    4. Latin America Fusion Biopsy Market, by End-Use
      1. By Hospitals
      2. By Diagnostic Centers
      3. By Ambulatory Care Centers
    5. Latin America Fusion Biopsy Market, by Country
      1. Brazil
        1. Brazil Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. Brazil Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
      2. Argentina
        1. Argentina Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. Argentina Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
      3. Rest of Latin America
        1. Rest of Latin America Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. Rest of Latin America Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
  8. Middle East & Africa Fusion Biopsy Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Fusion Biopsy Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Fusion Biopsy Market, by Biopsy Route
      1. By Transrectal
      2. By Transperineal
    4. Middle East & Africa Fusion Biopsy Market, by End-Use
      1. By Hospitals
      2. By Diagnostic Centers
      3. By Ambulatory Care Centers
    5. Middle East & Africa Fusion Biopsy Market, by Country
      1. GCC Countries
        1. GCC Countries Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. GCC Countries Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
      2. South Africa
        1. South Africa Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. South Africa Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Fusion Biopsy Market, By Biopsy Route
          1. By Transrectal
          2. By Transperineal
        2. Rest of Middle East & Africa Fusion Biopsy Market, By End-Use
          1. By Hospitals
          2. By Diagnostic Centers
          3. By Ambulatory Care Centers
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Eigen Technologies (U.S.)
    2. Koninklijke Philips N.V. (Netherlands)
    3. Hitachi Ltd. (Japan)
    4. MedCom (U.S.)
    5. ESAOTE SPA (Italy)
    6. KOELIS (France)
    7. Focal Healthcare (Canada)
    8. UC-Care Medical Systems Ltd. (U.S.)
    9. GeoScan Medical (U.S.)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
FAQ
Frequently Asked Question
  • The global Fusion Biopsy valued at USD 425.9 Million in 2022 and is expected to reach USD 929.8 Million in 2030 growing at a CAGR of 11.8%.

  • The prominent players in the market are Eigen Technologies (U.S.), Koninklijke Philips N.V. (Netherlands), Hitachi Ltd. (Japan), MedCom (U.S.), ESAOTE SPA (Italy), KOELIS (France), Focal Healthcare (Canada), UC-Care Medical Systems Ltd. (U.S.), GeoScan Medical (U.S.).

  • The market is project to grow at a CAGR of 11.8% between 2023 and 2030.

  • The driving factors of the Fusion Biopsy include

    • Increasing prevalence of prostate cancer

  • Asia Pacific was the leading regional segment of the Fusion Biopsy in 2022.